Nebuliser systems driven by electrically operated air compressors are being increasingly used in the treatment of asthma. These devices, which can deliver large doses of bronchodilator drugs in air, have been available in most hospitals for some years; used in conjunction with oxygen treatment, as they usually are, they appear to be both effective and safe in the treatment of severe acute asthma. In the home, however, nebulisers are almost invariably used without access to oxygen treatment. Because of the assumption that the inhalation of large amounts of nebulised bronchodilator solution such as 0.5% salbutamol may be dangerous in these circumstances, and because some patients may be prodigal in their use of these solutions, a single dose preparation of 2.5 mg salbutamol in 2.5 ml buffered normal saline (Ventolin Nebule) has recently been introduced for use with nebuliser systems. Little is known, however, of the efficacy and safety of this preparation in patients with severe acute asthma. In an attempt to determine whether the dose delivered is too large or too small, doses of salbutamol equivalent to a half, one and two Ventolin Nebules nebulised by an air compressor were compared in patients with severe acute asthma.
Methods
Thirty two patients presenting to hospital with severe acute asthma were studied. None Analysis of variance was used to compare the three treatment groups; linear regression analyses were used to examine the relationships between changes in FEV, FVC, Pao2, and pulse rate; and the correlation coefficient was used to test the association between the initial FEVI and FVC and the changes over two hours.
Results
All 30 patients had taken salbutamol or terbutaline 
